TRPM2 and glioblastoma: Univariate Cox analysis showed that TRPM2 expression was associated with overall survival (OS, p < 0.05) in BRCA, GBM, KIRC, LGG, LIHC, THYM, and UVM (Figure 3B); with disease-specific survival (DSS, p < 0.05) in BRCA, GBM, KIRC, LGG, THYM, and UVM; with disease-free interval (DFI, p < 0.05) in BRCA; with progression-free interval (PFI, p < 0.05) in BRCA, GBM, KIRC, LGG, THYM, and UVM (Figure S2A–C), while enhanced TRPM2 expression exerted a positive impact on survival in patients with SKCM and THCA.